baber/WOPTO huggingface dataset:
Patent AU-2019248314-A1 (AU)
Title: Data processing method and apparatus
Inventor: XU XIAOYING
IPC: H04L47/2416
Filed: 2019-04-04
Abstract: Provided are a data processing method and apparatus. In the data processing method. A first terminal acquires packet delay budget adjustment information, wherein the packet delay budget adjustment information is used for indicating an adjusted packet delay budget, or a packet delay budget adjustment amount or a packet delay budget adjustment range; the first terminal adjusts the size of a jitter buffer region according to the packet delay budget adjustment information; and then caches data according to the adjusted jitter buffer region. By means of the data processing method, the size of a jitter buffer region can be adjusted in a relatively rapid manner, such that the voice quality can be improved.
Patent AU-2019250770-A1 (AU)
Title: Amphiphilic asymmetrical diglycolamides and use thereof for extracting rare earth metals from acidic aqueous solutions
Inventor: ANDREIADIS EUGEN
IPC: C22B59/00
Filed: 2019-04-15
Abstract: The invention relates to new optimized amphiphilic asymmetrical diglycolamides suitable for use as rare earth metal extracting agents. Said diglycolamides have general formulae (I) and (II), where: R
Patent AU-2019290170-A1 (AU)
Title: Methods for treating cancer with bispecific anti-cd3xmuc16 antibodies and anti-pd-1 antibodies
Inventor: CRAWFORD ALISON
IPC: C07K16/28
Filed: 2019-06-20
Abstract: The methods of the present invention comprise administering to a subject in need thereof a therapeutically effective amount of an antibody or antigen-binding fragment thereof that specifically binds to programmed death 1 (PD-1) receptor in combination with a therapeutically effective amount of a bispecific antibody that specifically binds Mucin 16 (MUC16) and CD3.
Patent AU-2019301915-A1 (AU)
Title: Surgical instrument mounted display system
Inventor: MATA MARIO
IPC: A61B90/00
Filed: 2019-06-27
Abstract: A C-arm, or a mobile intensifier device, is one example of a medical imaging device that is based on X-ray technology. Because a C-arm device can display high-resolution X-ray images in real time, a physician can monitor progress at any time during an operation, and thus can take appropriate actions based on the displayed images. Monitoring the images, however, is often challenging during certain procedures, for instance during procedures in which attention must be paid to the patient's anatomy as well as a medical imaging device display. In an example, a surgical instrument assembly includes a processor, a surgical instrument configured to operate on an anatomical structure, and a display coupled to the processor and attached to the surgical instrument. The display can be configured to display visual information comprising X-ray images generated by a medical imaging device, and depth guage information generated by a depth gauge coupled to the surgical instrument.
Patent AU-2019308940-A1 (AU)
Title: Crystal form of lanosterol prodrug compound and application thereof
Inventor: LIU YIZHI
IPC: A61K31/573
Filed: 2019-07-25
Abstract: The present invention relates to a crystal form of a compound of formula (I) and an application thereof in preparing a drug for treating an ophthalmic disease.
Patent AU-2019340237-A1 (AU)
Title: A water vessel hull protector and method of construction
Inventor: BARBER MARK
IPC: B63C1/02
Filed: 2019-09-10
Abstract: A water vessel hull protector including a support frame defining an internal volume within which a watercraft can be removably located and at least one barrier skin configured to extend across the internal volume of the support frame, and mounted to the support frame to extend above the waterline to separate the support frame from an external water body in order to prevent fouling of the support frame by marine growth.
Patent AU-2019400901-A1 (AU)
Title: Method for igniting an assembly of electronic detonators
Inventor: BIARD LIONEL
IPC: F42D1/055
Filed: 2019-12-17
Abstract: A method for igniting an assembly of electronic detonators (1) comprises: - receipt, by a receiving device (30) associated with one or more electronic detonators (1), of an ignition command from a transmitted sequence of ignition commands (100) comprising at least two ignition commands, a synchronisation delay (t2, t4) being associated with each ignition command; - counting down, from the time of receipt of the ignition command, the synchronisation delay (t2, t4) associated with the received ignition command; - counting down an ignition delay (t
Patent AU-2019414331-A1 (AU)
Title: Nanocapsules for the delivery of cell modulating agents
Inventor: YAN MING
IPC: A61K48/00
Filed: 2019-12-23
Abstract: The present disclosure is directed to polymer nanocapsules including a ribonucleoprotein complex, and methods of their delivery. In some embodiments, the polymer nanocapsule comprises a polymer shell and a ribonucleoprotein complex, wherein the polymer shell comprises at least one positively charged monomer, at least one neutral monomer, and a crosslinker. Also disclosed are conjugates of polymer nanocapsules coupled to one or more targeting moieties and/or one or more stabilizing moieties.
Patent AU-2019444497-A1 (AU)
Title: Formulations for additive manufacturing of three-dimensional objects containing sinterable materials
Inventor: PELED HAGAI
IPC: B28B1/00
Filed: 2019-05-07
Abstract: A sinterable paste formulation usable as cast material in a cast-mold process, in combination with a mold material formulation, is provided. The sinterable paste formulation comprises a power of a sinterable material, in an amount of at least 85 % by weight of the total weight of the formulation, a binder as described in the specification, and an aqueous solution which comprises water and a water-miscible organic solvent featuring an evaporation rate in a range of from 0.3 to 0.8 on an n-butyl acetate scale. Methods employing the formulation and objects and products obtained therefrom are also provided.
Patent AU-2019450008-A1 (AU)
Title: Water-activated mucoadhesive compositions and methods of delivering biologically active substances
Inventor: LEE YUHAN
IPC: A61K47/30
Filed: 2019-06-10
Abstract: This disclosure relates to compositions including formulated sucralfate or other aluminum-crosslinked sulfated agents and one or more biologically active substances to mucosal surfaces within the GI tract and methods for the manufacture and the use of these compositions.
Patent WO-2020172706-A1 (WO)
Title: Proximity proofing electronic transactions
Inventor: JAMES ADRIAN
IPC: H04W12/00
Filed: 2020-02-25
Abstract: A computer implemented method for authorising a transaction by ensuring an accurate determination of the mobile device and the terminal. Further discussed are transactions that must occur within a specified proximity. The method includes calculating an adjusted and/or assured position of the mobile device by adjusting and/or assuring the approximate position of the mobile device using bespoke device positioning or position assurance systems based on the one or more local transmission services available to the mobile device, calculating an adjusted or assured position of the terminal by assuring the approximate position of the terminal using bespoke device position adjustment or assurance systems based on the one or more local transmission services available to the terminal and authorising the electronic transaction by the mobile device if the adjusted and/or assured position of the mobile device and the adjusted and/or assured position of the terminal are within an authorised operating location.
Patent AU-2020200635-A1 (AU)
Title: Management system for game token coin
Inventor: SHIGETA YASUSHI
IPC: H04B5/02
Filed: 2020-01-29
Abstract: In a management system of a game token coin, one RFID 
tag having a data non-rewritable region and a data 
rewritable region is imparted to the game token coin. The 
location relating information of the game token coin is 
stored in the data rewritable region. The system includes 
a writer configured to additionally write the location 
relating information, a reader configured to read the 
location relating information from a plurality of the game 
token coins, and a management controller configure to 
examine the information obtained from the reader. The 
management controller includes a function that determines 
whether a history of the location relating information 
obtained from the reader has no abnormality.  
46
1/14 
2 
21 22 
-y 
221 222 223 
DATE AND 
TIME AND PLACE,EVENT OWNER 
HOUR 
2019/1/28 PRODUCED 
13:00 AT FACTORY 
2019/2/10 ACCEPTED CSN 
11:03 IN CASINO CSN 
2019/22 CAGE PLAYER-A 
2016:5 TABLE NO. 325 PLAYER-A 
2016:3 TABLE NO. 325 PLAYER-B 
2019/2/27 LEAVING PLAYER-B 
17:01 
2019/2/28 ENTERING PLAYER-B 
0:40 
FIG.1I
Patent AU-2020202038-A1 (AU)
Title: Implantable devices and techniques for oncoplastic surgery
Inventor: LEBOVIC GAIL S
IPC: A61F2/12
Filed: 2020-03-20
Abstract: Described herein are devices for placement in surgically created soft tissue spaces, potential spaces, or cavities. The implantable devices generally include a bioabsorbable body having an open framework that facilitates attachment of tissue thereto in a manner that helps avoid post-surgical deformities. Methods for using the implantable devices in oncoplastic surgery are further described.
Patent AU-2020202208-A1 (AU)
Title: Purification device
Inventor: JEON JEWOOK
IPC: B01D35/30
Filed: 2020-03-27
Abstract: A purification device comprises a main body having an open extending horizontally; a rotator in the opening to be rotatably mounted on the main body; and a manipulation structure spaced from and above the rotator and rotatably connected to a top face of the main body, the manipulation structure protruding forward of the main body. The device also includes a water-outlet module with a fixed cover fixed to the rotator through the opening, the fixed cover protruding forward of the main body, and a top of the fixed cover being connected to a bottom of the manipulation structure; a vertically-movable cover held in contact with the fixed cover; and a water-outlet nozzle mounted onto a bottom of the vertically-movable cover. When the vertically-movable cover rises to a highest level, a top of the vertically-movable cover is located in a space between the rotator and the manipulation structure.
Patent AU-2020204009-A1 (AU)
Title: Method and apparatus for distributing an available energy quantity in a local network
Inventor: SCHMIEGEL ARMIN UWE
IPC: H02J4/00
Filed: 2020-06-16
Abstract: The invention relates to a method (200) for distributing the available 
amount of energy in a local energy network (100). In a reading-in step 
(202), an energy plan (112, 114, 116, 118) for a component (104, 106, 
5 108, 110) is read in from the central computer (102) that controls the 
energy network (100). In a receiving step (204), instantaneous 
consumption information (128, 130, 132, 134) regarding at least one other 
component (104, 106, 108, 110) of the local energy network (100) is 
received. In an allocation step (206), energy (312) is allocated to the 
10 component (104, 106, 108, 110) and the other component (104, 106, 108, 
110), using the consumption information (128, 130, 132, 134) the 
component'[s (104, 106, 108, 110) own consumption, and the energy plan 
(112, 114, 116, 118).  
2569668v1
Patent AU-2020206014-A1 (AU)
Title: A liquid agricultural adjuvant
Inventor: BERG PAULO SERGIO
IPC: A01N25/02
Filed: 2020-01-08
Abstract: This disclosure provides for a liquid agricultural adjuvant, comprising: at least one alkyl (C
Patent AU-2020206446-A1 (AU)
Title: Device for coating aggregates, method and uses
Inventor: LOUBIER MARTIN
IPC: E01C19/05
Filed: 2020-01-07
Abstract: The invention relates to a coating device able to manufacture bituminous coatings comprising: at least one means for supplying at least one aggregate, such as a recycled aggregate, to a mixer and/or a drying drum, said supply means having an upper face able to receive the aggregate, several groups of infrared emitters, disposed in line with said upper face of said at least one supply means and able to emit a wavelength that substantially corresponds to the maximum wavelength in the determined absorption spectrum of said at least one aggregate at a desired temperature, each group of infrared emitters being able to emit a specific wavelength that is different between each group, said at least one supply means being able to and/or configured to withstand the electromagnetic radiation emitted by said groups of infrared emitters. The invention also relates to the method for implementing the aforementioned device, as well as to its uses.
Patent AU-2020223757-A1 (AU)
Title: Prevention and Screening Method
Inventor: LIEBERT ANN
IPC: A61N5/067
Filed: 2020-08-28
Abstract: The present invention relates to a method of preventing or reducing one or 
more adverse post-anaesthetic effects in a patient, comprising treating the patient 
5 with low level laser therapy (LLLT) prior to anaesthesia and/or during anaesthesia 
and/or following anaesthesia, and to a method for assessing whether a patient is 
at risk of suffering from adverse post-anaesthetic effects, comprising determining 
whether the patient contains a polymorphism in a gene encoding one of the 
following proteins: (a) protein associated with assembly and disassembly of 
10 microtubules; (b) ion channel protein; (c) membrane stability protein; (d) 
Melanocortin systems proteins; (e) proteins associated with Alzheimer's and/or 
Parkinson's vulnerability; or (f) proteins associated with migraine.  
W:\NRPortbl\GHMatters\MICHELES\12347864_1.docx11/05/20
Patent AU-2020230331-A1 (AU)
Title: Artificial Stomach
Inventor: FORSELL PETER
IPC: A61F2/04
Filed: 2020-09-11
Abstract: An artificial stomach for replacing the normal stomach of a patient comprises a food reservoir adapted 
to collect food, an inlet connected to a first opening of the food reservoir and further being adapted to 
upstream connect to the patient's gastrointestinal tract, and an outlet connected to a second opening of 
the food reservoir and further being adapted to downstream connect to the patient's gastrointestinal 
tract.
17/19 
202 44 
117 44b 
506 44a 
11 568 118 
14 
554 556 
12 90 52 
550 552 
214 15 
13 
10 
Fig. 33
Patent AU-2020233739-A1 (AU)
Title: Machine-Learning Techniques For Monotonic Neural Networks
Inventor: TURNER MATTHEW
IPC: G06Q99/00
Filed: 2020-09-17
Abstract: In some aspects, a computing system can generate and optimize a neural network for risk 
assessment. The neural network can be trained to enforce a monotonic relationship between each 
of the input predictor variables and an output risk indicator. The training of the neural network 
can involve solving an optimization problem under a monotonic constraint. This constrained 
optimization problem can be converted to an unconstrained problem by introducing a Lagrangian 
expression and by introducing a term approximating the monotonic constraint. Additional 
regularization terms can also be introduced into the optimization problem. The optimized neural 
network can be used both for accurately determining risk indicators for target entities using 
predictor variables and determining explanation codes for the predictor variables. Further, the risk 
indicators can be utilized to control the access by a target entity to an interactive computing 
environment for accessing services provided by one or more institutions.  
49
Patent AU-2020235820-A1 (AU)
Title: Negative pressure treatment arrangement
Inventor: NOT GIVEN
IPC: A61M1/00
Filed: 2020-03-11
Abstract: A negative pressure treatment arrangement comprising a multi-layered drainage film, wherein a drainage space is formed between two layers of the drainage film, a first film layer on the wound side delimiting the drainage space comprising a first opening arrangement facilitating the admission of fluids or gases to the drainage space and a second film layer facing away from the wound that also delimits the drainage space comprising a second opening arrangement designed to discharge fluids and/or gases from the drainage space, and also comprising a fluid-tight fixing film that can be used to fix the drainage film to the skin surrounding a wound and to cover at least one area of the second opening arrangement.
Patent AU-2020239663-A1 (AU)
Title: DNA-encoded libraries having encoding oligonucleotide linkages not readable by polymerases
Inventor: KEEFE ANTHONY D
IPC: C12N15/11
Filed: 2020-09-22
Abstract: The present invention relates to complexes of oligonucleotide-encoded libraries and methods of tagging 
5 and using such libraries. In particular, the oligonucleotides and methods can include complexes having at least one 
linkage for which a polymerase has reduced ability to read or translocate through.
Patent AU-2020239717-A1 (AU)
Title: User interfaces for managing media
Inventor: MANZARI BEHKISH J
IPC: G06F3/0484
Filed: 2020-09-24
Abstract: The present disclosure generally relates to user interfaces for managing exposure 
compensation when capturing media (e.g., an image, video), displaying representations of media 
(an image, video), and displaying a status indicator (e.g., status indicator indicating that media is 
and/or has been captured).
Patent AU-2020252137-A1 (AU)
Title: Anti-aging cosmetic composition
Inventor: AURIOL DANIEL
IPC: A61K8/60
Filed: 2020-03-30
Abstract: A cosmetic active agent comprising a mixture of mannose-6-phosphate and mannose is disclosed.
Patent AU-2020253455-A1 (AU)
Title: Anti-alpha beta TCR binding polypeptides with reduced fragmentation
Inventor: QIU HUAWEI
IPC: C07K16/28
Filed: 2020-04-02
Abstract: The present disclosure is related to improved compositions and methods for treating T-cell-mediated diseases and disorders (e.g., autoimmune disorders, graft- versus-host-disease, and graft rejection). Provided are anti-apβTCR binding polypeptides, including antibodies, which comprise at least one amino acid substitution or modification that increases the stability of the binding polypeptide by reducing fragmentation of the light chain variable region. The methods provided herein generally involve administering to a subject in need thereof an effective amount of a stabilized, humanized binding polypeptide that is specific to the alpha beta T-cell receptor (apβTCR).
Patent AU-2020283069-A1 (AU)
Title: Optimized phenylalanine hydroxylase expression
Inventor: LAHUSEN TYLER
IPC: C12N9/02
Filed: 2020-06-01
Abstract: A lentiviral vector system for expressing a lentiviral particle is disclosed. The lentiviral vector system includes a therapeutic vector. The lentiviral vector system produces a lentiviral particle that encodes a codon-optimized PAH for upregulating PAH expression in the cells of a subject afflicted with phenylketonuria (PKU).
Patent AU-2020286219-A1 (AU)
Title: Cochlear Implant Hearing Aid System
Inventor: BESNARD MARTIN
IPC: H04R25/00
Filed: 2020-12-08
Abstract: A cochlear implant hearing aid system is disclosed. The system comprises an external unit 
configured to receive acoustic sound and process the acoustic sound into a coded audio 
5 signal, and an implantable unit configured to receive the coded audio signal. Further, the 
external unit comprises a power supply unit connected via a first path to a switching unit, 
wherein the switching unit is connected via a second path to ground and is connected at an 
output thereof to a first coil. Furthermore, the switching unit is configured to operate as a 
switching element configured to switch between switching states, wherein the switching 
10 states include a first state for applying and a second state for not applying a current to the 
first coil. The coded audio signal is supplied to the switching unit as a control signal, and the 
first coil is inductively linked to a second coil arranged in the implantable unit. The system 
further comprises a measuring unit connected to at least one of the first and second paths 
and configured to measure a dissipative current occurring in relation to the switching states 
15 of the switching unit. Based on the at least one measured dissipative current, a resonance 
frequency of the inductive link between the first and second coils is adapted.  
(Figure 1 is to be published)
1/8 
r - - - - - - - - - 9 
0) a) 
a) U a 
0 CU%4 
Et '0) 10'
'a .9 " ------
U) 
L- - - ---- J -a 
IN C-) , 
(j) ::o
Patent AU-2020308592-A1 (AU)
Title: IL2 agonists
Inventor: SAHIN UGUR
IPC: C07K14/55
Filed: 2020-06-23
Abstract: The invention relates to variants of interleukin-2 (IL2). In particular, the invention relates to a polypeptide comprising a mutein of human IL2 or of a functional variant of human IL2, wherein the human IL2 or functional variant thereof is substituted such that affinity for the βγ IL2 receptor complex (ΙL2Rβγ) is enhanced. In one embodiment, the human IL2 or functional variant thereof is further substituted such that affinity for the αβγ IL2 receptor complex (IL2αβγ) is reduced. In one embodiment, the polypeptide activates effector T cells over regulatory T cells. The invention also relates to polynucleotides coding for the polypeptides of the invention, host cells comprising the polynucleotides, pharmaceutical compositions comprising the polypeptides, polynucleotides or host cells, therapeutic or prophylactic methods of treatment using the polypeptides, polynucleotides, host cells or pharmaceutical compositions and medical preparations comprising the polypeptides, polynucleotides, host cells or pharmaceutical compositions.
Patent AU-2020314650-A1 (AU)
Title: Opioid growth factor receptor (OGFR) antagonists, in particular naloxone and/or naltrexone for treating cancer
Inventor: MARGULIES BRYAN S
IPC: A61K31/485
Filed: 2020-07-14
Abstract: This disclosure relates to methods and compositions for treating cancer by administering opioid growth factor receptor (OGFR) antagonists. In particular, the present disclosure relates to methods of administering OGFR antagonists locally to the site of cancer cells in the patient diagnosed with cancer.
Patent AU-2020318823-A1 (AU)
Title: Selectively-pliable chemical vapor deposition (CVD) diamond or other heat spreader
Inventor: ALTMAN DAVID H
IPC: H01L21/48
Filed: 2020-06-16
Abstract: A system includes at least one component (108) configured to generate thermal energy, a heat spreader (100) configured to remove thermal energy from the at least one component, and at least one substrate (110) configured to remove thermal energy from the heat spreader. The heat spreader includes a first portion (102) and a second portion (104). The first portion of the heat spreader is coupled to the substrate, and the second portion of the heat spreader is coupled to the at least one component. The first portion of the heat spreader includes high aspect-ratio structures (106) that are separated from one another. The high aspect-ratio structures cause the first portion of the heat spreader to be pliable and able to accommodate a mismatch in coefficients of thermal expansion between a material in the heat spreader and a material in the substrate.